BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24383889)

  • 21. In vitro platelet release by rat megakaryocytes: effect of heterologous antiplatelet serum.
    Handagama PJ; Jain NC; Feldman BF; Farver TB; Kono CS
    Am J Vet Res; 1987 Jul; 48(7):1147-9. PubMed ID: 3631702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-4 downregulates nuclear factor-erythroid 2 (NF-E2) expression in primary megakaryocytes and in megakaryoblastic cell lines.
    Catani L; Amabile M; Luatti S; Valdrè L; Vianelli N; Martinelli G; Tura S
    Stem Cells; 2001; 19(4):339-47. PubMed ID: 11463954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vps34 derived phosphatidylinositol 3-monophosphate modulates megakaryocyte maturation and proplatelet production through late endosomes/lysosomes.
    Bertović I; Kurelić R; Milošević I; Bender M; Krauss M; Haucke V; Jurak Begonja A
    J Thromb Haemost; 2020 Jul; 18(7):1756-1772. PubMed ID: 32056354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of the megakaryocyte demarcation membrane system and its role in thrombopoiesis.
    Schulze H; Korpal M; Hurov J; Kim SW; Zhang J; Cantley LC; Graf T; Shivdasani RA
    Blood; 2006 May; 107(10):3868-75. PubMed ID: 16434494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A role for Rab27b in NF-E2-dependent pathways of platelet formation.
    Tiwari S; Italiano JE; Barral DC; Mules EH; Novak EK; Swank RT; Seabra MC; Shivdasani RA
    Blood; 2003 Dec; 102(12):3970-9. PubMed ID: 12907454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclin D3 and megakaryocyte development: exploration of a transgenic phenotype.
    Zimmet JM; Toselli P; Ravid K
    Stem Cells; 1998; 16 Suppl 2():97-106. PubMed ID: 11012182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deregulated expression of c-myc in megakaryocytes of transgenic mice increases megakaryopoiesis and decreases polyploidization.
    Thompson A; Zhang Y; Kamen D; Jackson CW; Cardiff RD; Ravid K
    J Biol Chem; 1996 Sep; 271(38):22976-82. PubMed ID: 8798484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The HDAC inhibitor Givinostat modulates the hematopoietic transcription factors NFE2 and C-MYB in JAK2(V617F) myeloproliferative neoplasm cells.
    Amaru Calzada A; Todoerti K; Donadoni L; Pellicioli A; Tuana G; Gatta R; Neri A; Finazzi G; Mantovani R; Rambaldi A; Introna M; Lombardi L; Golay J;
    Exp Hematol; 2012 Aug; 40(8):634-45.e10. PubMed ID: 22579713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Actin reorganization and proplatelet formation in murine megakaryocytes: the role of protein kinase calpha.
    Rojnuckarin P; Kaushansky K
    Blood; 2001 Jan; 97(1):154-61. PubMed ID: 11133755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen promotes megakaryocyte polyploidization via estrogen receptor beta-mediated transcription of GATA1.
    Du C; Xu Y; Yang K; Chen S; Wang X; Wang S; Wang C; Shen M; Chen F; Chen M; Zeng D; Li F; Wang T; Wang F; Zhao J; Ai G; Cheng T; Su Y; Wang J
    Leukemia; 2017 Apr; 31(4):945-956. PubMed ID: 27748371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down-regulation of stathmin expression is required for megakaryocyte maturation and platelet production.
    Iancu-Rubin C; Gajzer D; Tripodi J; Najfeld V; Gordon RE; Hoffman R; Atweh GF
    Blood; 2011 Apr; 117(17):4580-9. PubMed ID: 21364187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood platelets are assembled principally at the ends of proplatelet processes produced by differentiated megakaryocytes.
    Italiano JE; Lecine P; Shivdasani RA; Hartwig JH
    J Cell Biol; 1999 Dec; 147(6):1299-312. PubMed ID: 10601342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uncoupling of the Hippo and Rho pathways allows megakaryocytes to escape the tetraploid checkpoint.
    Roy A; Lordier L; Pioche-Durieu C; Souquere S; Roy L; Rameau P; Lapierre V; Le Cam E; Plo I; Debili N; Raslova H; Vainchenker W
    Haematologica; 2016 Dec; 101(12):1469-1478. PubMed ID: 27515249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of megakaryocytopoiesis.
    Avraham H
    Stem Cells; 1993 Nov; 11(6):499-510. PubMed ID: 8111309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NF-E2, FLI1 and RUNX1 collaborate at areas of dynamic chromatin to activate transcription in mature mouse megakaryocytes.
    Zang C; Luyten A; Chen J; Liu XS; Shivdasani RA
    Sci Rep; 2016 Jul; 6():30255. PubMed ID: 27457419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interpreting the developmental dance of the megakaryocyte: a review of the cellular and molecular processes mediating platelet formation.
    Machlus KR; Thon JN; Italiano JE
    Br J Haematol; 2014 Apr; 165(2):227-36. PubMed ID: 24499183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small Molecule Supplements Improve Cultured Megakaryocyte Polyploidization by Modulating Multiple Cell Cycle Regulators.
    Zou X; Qu M; Fang F; Fan Z; Chen L; Yue W; Xie X; Pei X
    Biomed Res Int; 2017; 2017():2320519. PubMed ID: 29201898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Megakaryocyte development and platelet production.
    Deutsch VR; Tomer A
    Br J Haematol; 2006 Sep; 134(5):453-66. PubMed ID: 16856888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The spectrin-based membrane skeleton stabilizes mouse megakaryocyte membrane systems and is essential for proplatelet and platelet formation.
    Patel-Hett S; Wang H; Begonja AJ; Thon JN; Alden EC; Wandersee NJ; An X; Mohandas N; Hartwig JH; Italiano JE
    Blood; 2011 Aug; 118(6):1641-52. PubMed ID: 21566095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro platelet release by rat megakaryocytes: effect of metabolic inhibitors and cytoskeletal disrupting agents.
    Handagama PJ; Feldman BF; Jain NC; Farver TB; Kono CS
    Am J Vet Res; 1987 Jul; 48(7):1142-6. PubMed ID: 3631701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.